Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 82.02%-93.62K | -110.88%-603.01K | 13.93%-48.68K | -41.91%-1.37M | -75.59%-509.66K | 6.63%-520.8K | -8,183.52%-285.95K | 51.25%-56.56K | 10.73%-967.51K | 49.41%-290.25K |
| Net income from continuing operations | 146.56%99.34K | 133.24%95.32K | 335.69%207.07K | 429.17%8.02M | 600.51%8.61M | 13.81%-213.38K | 5.71%-286.76K | 46.72%-87.86K | 2.69%-2.44M | 5.94%-1.72M |
| Operating gains losses | ---- | ---- | ---- | ---9.02M | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | -48.47%5.41K | 97.45%5.41K | 69.76%5.41K | -57.46%11.41K | -164.26%-5.03K | 10.56%10.51K | 21.35%2.74K | -55.88%3.19K | -7.24%26.81K | 8.26%7.82K |
| Asset impairment expenditure | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -18.66%1.47M | ---- |
| Unrealized gains and losses of investment securities | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 66.67%37.5K | ---- |
| Remuneration paid in stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | -85.34%6.41K | 100.00%-1 |
| Other non cashItems | 100.70%402 | -106.23%-85.98K | -55.55%-180.01K | -372.96%-371.41K | -211.22%-156.94K | -646.58%-57.05K | -286.69%-41.69K | -1,095.54%-115.73K | 57.32%-78.53K | 60.82%-50.43K |
| Change In working capital | 31.16%-198.77K | -1,054.17%-617.76K | -155.31%-81.16K | -223.11%-11.21K | 238.93%66.06K | 0.95%-288.75K | -78.15%64.74K | 183.21%146.74K | 104.24%9.11K | 86.68%-47.55K |
| -Change in receivables | -17,438.80%-181.7K | -807.15%-218.45K | -606.50%-262.44K | -267.99%-137.82K | -724.07%-130.52K | -105.46%-1.04K | 329.58%30.89K | -140.22%-37.15K | 180.04%82.04K | 64.36%-15.84K |
| -Change in prepaid assets | 455.91%3.76K | -81.28%3.82K | -160.76%-8.34K | -34.35%43.17K | 207.16%27.02K | -10.33%-1.06K | -57.70%20.4K | -132.99%-3.2K | 221.21%65.76K | 104.99%8.8K |
| -Change in payables and accrued expense | 90.60%-20.83K | -3,097.44%-403.13K | 1.36%189.63K | 160.16%83.44K | 256.92%104.58K | -86.43%-221.68K | -86.86%13.45K | 437.22%187.08K | -412.93%-138.7K | 73.42%-66.65K |
| -Change in other current liabilities | ---- | ---- | ---- | ---- | ---- | 77.44%-37.1K | ---- | ---- | ---- | ---- |
| -Change in other working capital | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -77.99%1.15K | ---- | ---- |
| Interest paid (cash flow from operating activities) | ---- | --0 | --0 | ---- | ---- | --27.88K | ---24.98K | -12.32%-2.9K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 82.02%-93.62K | -110.88%-603.01K | 13.93%-48.68K | -41.91%-1.37M | -75.59%-509.66K | 6.63%-520.8K | -8,185.92%-285.95K | 51.25%-56.56K | 10.73%-967.51K | 49.41%-290.25K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 120.62%34.3K | 345.72%263.38K | 164.26%356.62K | 215.76%433.06K | 17,180.51%1.26M | -44.31%-166.3K | 20.80%-107.19K | -324.18%-554.92K | 73.63%-374.11K | 101.08%7.3K |
| Net PPE purchase and sale | 48.58%-85.51K | -188.05%-308.76K | -7.59%-597.06K | 1,020.03%3.44M | 58,396.99%4.27M | -44.31%-166.3K | 20.80%-107.19K | -324.18%-554.92K | 73.63%-374.11K | 101.08%7.3K |
| Net investment purchase and sale | --119.81K | --572.15K | --953.68K | ---3.01M | ---3.01M | --0 | --0 | --0 | --0 | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 120.62%34.3K | 345.72%263.38K | 164.26%356.62K | 215.76%433.06K | 17,180.51%1.26M | -44.31%-166.3K | 20.80%-107.19K | -324.18%-554.92K | 73.63%-374.11K | 101.08%7.3K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -100.59%-5.13K | -101.08%-5.13K | -101.25%-5.13K | -20.03%950.36K | -3,083.94%-809.1K | 40.07%875K | -20.05%475K | 8,169.73%409.46K | 19.77%1.19M | -400.63%-25.41K |
| Net issuance payments of debt | 95.90%-5.13K | -101.08%-5.13K | -101.25%-5.13K | -131.65%-44.1K | -20,963.20%-803.56K | -2,363.05%-125K | 9,459.61%475K | 8,169.73%409.46K | 6.21%-19.04K | 24.84%-3.82K |
| Net common stock issuance | ---- | ---- | ---- | -16.67%1M | --0 | 66.45%1M | -93.32%40K | ---40K | 18.52%1.2M | --0 |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- | --29K | --0 |
| Net other financing activities | ---- | ---- | ---- | 74.34%-5.54K | ---- | ---- | ---- | ---- | ---21.6K | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -100.59%-5.13K | -101.08%-5.13K | -101.25%-5.13K | -20.03%950.36K | -3,083.94%-809.1K | 40.07%875K | -20.05%475K | 8,169.73%409.46K | 19.77%1.19M | -400.63%-25.41K |
| Net cash flow | ||||||||||
| Beginning cash position | 86.41%191.25K | 2,485.18%536.01K | 4.69%233.21K | -40.76%222.76K | -45.31%290.5K | -82.29%102.6K | -83.29%20.73K | -40.76%222.76K | -80.07%376.01K | -67.39%531.12K |
| Current changes in cash | -134.30%-64.45K | -521.14%-344.76K | 249.88%302.81K | 106.82%10.45K | 81.42%-57.29K | 488.80%187.9K | -82.02%81.86K | 19.80%-202.03K | 89.85%-153.25K | 75.39%-308.36K |
| End cash Position | -56.35%126.8K | 86.41%191.25K | 2,485.18%536.01K | 4.69%233.21K | 4.69%233.21K | -45.31%290.5K | -82.29%102.6K | -83.29%20.73K | -40.76%222.76K | -40.76%222.76K |
| Free cash from | 73.93%-179.13K | -131.92%-911.77K | -5.60%-645.75K | -118.48%-2.93M | -338.02%-1.24M | -2.09%-687.1K | -183.25%-393.14K | -147.73%-611.48K | 46.39%-1.34M | 77.32%-282.95K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.